Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.

Saved in:
Bibliographic Details
Title: Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.
Authors: Gao Y; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia., Souza-Fonseca-Guimaraes F; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia.; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia., Bald T; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Ng SS; Immunology and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Natural Sciences, Griffith University, Nathan, Queensland, Australia., Young A; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia., Ngiow SF; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Rautela J; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia., Straube J; Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Waddell N; Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Blake SJ; Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Yan J; School of Medicine, The University of Queensland, Herston, Queensland, Australia.; Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Bartholin L; Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France., Lee JS; Control of Gene Expression Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Vivier E; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France., Takeda K; Division of Cell Biology, Biomedical Research Center and Department of Biofunctional Microbiota, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan., Messaoudene M; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France.; Gustave Roussy Cancer Campus, Villejuif, France., Zitvogel L; Gustave Roussy Cancer Campus, Villejuif, France.; University Paris-Saclay, Kremlin Bicêtre, Paris, France.; CIC1428, Gustave Roussy Cancer Campus, Villejuif, France., Teng MWL; School of Medicine, The University of Queensland, Herston, Queensland, Australia.; Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Belz GT; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia., Engwerda CR; Immunology and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Huntington ND; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia., Nakamura K; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Hölzel M; Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany., Smyth MJ; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. mark.smyth@qimrberghofer.edu.au.; School of Medicine, The University of Queensland, Herston, Queensland, Australia. mark.smyth@qimrberghofer.edu.au.
Source: Nature immunology [Nat Immunol] 2024 May; Vol. 25 (5), pp. 925-926.
Publication Type: Published Erratum
Journal Info: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1529-2916
DOI:10.1038/s41590-024-01799-9